Analysis of fiducial markers used for on-line verification in the external-beam radiotherapy of patients with cranial tumours
Evaluate the fiducial marker-based position verification in the external-beam radiotherapy of patients with cranial tumour.
Thirteen patients with intracranial tumours were treated with external-beam radiotherapy using 3 gold markers implanted in the skull. Before each fraction the patient was positioned on the treatment table and 2 orthogonal portal images were performed to localise the 3 gold seeds and the target position was calculated using a commercialised computer program (ISOLOC software, MEDTEC). This program provides the couch movements required to move the target to the isocentre.
When the set-up error was corrected using the coordinates of the 3 markers, the final movements were less than 2 mm in all cases: lateral, mean v., 1.21 mm; longitudinal, 1.23 mm; and anteroposterior, 1.18 mm. No serious complications related to the gold marker insertion were noted.
The use of 3 implanted fiducial seeds is an optimal technique for precise set-up in patients with brain tumours treated with external radiotherapy. This commercial system is highly suitable for fractionated stereotactic irradiation.
Key wordsFiducial markers Stereotactic radiosurgery Cranial tumour On-line localisation
Unable to display preview. Download preview PDF.
- 1.Acculoc® implanted fiducial localisation system. www.medtec.comGoogle Scholar
- 6.Martínez JA, Lobato M, García F et al (2005) Utilización de implantes Fiduciales en Radioterapìa craneal y próstatica con sistema de posicionamiento ACCULOC®. XV Congreso Nacional de Física Médica, Pamplona, JulyGoogle Scholar
- 7.Loeffler JS, Kooy HM, Wen PY et al (1990) The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clinic Oncol 8:576–582Google Scholar
- 10.Steele G (1997) Basic clinical radiobiology, 2nd Edn. Arnold, LondonGoogle Scholar
- 23.Aoki M, Abe Y, Hatayama Y et al (2006) Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole-brain irradiation. Int J Radiat Oncol Biol Phys 64:414–418PubMedCrossRefGoogle Scholar